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Key Points 
• Human reproductive function adjusts to changing environmental conditions 
• Key ‘windows of susceptibility’ during various stages of early development are the most 
sensitive to events or exposures which can impart long-term re-programming of adult 
reproductive function 
• Epigenetic modifications have a role in regulating the central control of reproduction and 
pubertal onset, and likely mediate much of the adaptive response 
• Human cohort data is useful for identifying methylation in proxy tissues that correlates with 
phenotypic variation, but determining cause-effect is challenging because hormones affect 
the epigenome and epigenetic ageing  
• Understanding which of the modifications are functional and responsible for the phenotype 
requires integrating the study of human tissues, animal and cell models and molecular 
approaches 
• Characterization and elucidation of these adaptive mechanisms are needed to inform the 
clinician of alternative reproductive strategies, and the implications for fertility treatment 






Reproductive function adjusts in response to environmental conditions in order to optimize success. 
In humans, this plasticity includes age of pubertal onset, hormone levels and age at menopause, all of 
which have broad health implications. These reproductive characteristics vary across populations 
with distinct lifestyles and following specific childhood events, and point to a role for the early-life 
environment in shaping adult reproductive trajectories, as well as moderation of the response by 
other biological systems. Epigenetic mechanisms respond to external signals, exert long-term effects 
on gene expression, and have been shown in animal and cellular studies to regulate normal 
reproductive function, strongly implicating their role in these adaptations. Moreover, human cohort 
data have revealed differential DNA methylation signatures in proxy tissues that are associated with 
reproductive phenotypic variation, although the cause-effect relationships are difficult to discern, 
calling for additional complementary approaches to establish functionality. The influence of 
childhood environment on adult reproductive function, with associated health consequences, is an 
important consideration in understanding how reproduction is regulated, and necessitates 
consideration by clinicians treating women with diverse life histories. Resolution of the molecular 
mechanisms responsible for human reproductive plasticity could also lead to new approaches for 
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[H1] Introduction  
The reproductive endocrine axis is dynamic and responds to multiple environmental signals that 
provide the plasticity for optimization of reproductive success over an individual’s life-span1,2 . The 
mechanisms governing and regulating this adaptability are not fully understood but changes in the 
regulatory epigenetic landscape (Box 1) undoubtedly play a central role. The epigenome is responsive 
to external signals and is able to modify gene expression patterns and networks3, enabling it to direct 
changes in reproductive function in response to differing environments. However, the effects of 
early-life circumstances on adult reproductive function vary, depending both on the timing of events 
relative to ‘windows of susceptibility’, and between individuals growing up in industrialized settings 
and those in the developing world who have very different life styles4–9. This plasticity and the precise 
nature of the altered reproductive traits likely depend on resource availability, and clearly involve 
interactions between multiple physiological systems10–13. 
The role of the epigenome in the central control of reproduction has been the focus of several 
studies utilizing animal and cell models over the past decade or so14–28, whose findings comprise the 
basis of our current understanding on how adaptive reproductive strategies can be implemented. 
However, a reciprocal interaction also exists whereby reproductive hormones affect the epigenome 
and epigenetic ageing29–34, which complicates distinguishing cause from effect. This ambiguity is 
especially important when trying to understand regulatory processes from human data, in which 
experimental work and tissue accessibility are limited. Consequently, the importance of correlations 
identified in many of ‘big data’ sets from large human population cohort studies is often unclear, and 
the mechanistic basis of particular phenotypes remains ambiguous. More integrated approaches are 
warranted, including animal models to verify that the epigenetic modifications occur in the functional 
tissues. Subsequently, manipulations and in vitro experiments are necessary to define the actual role 
of the modifications on gene expression and whether they are responsible for the phenotype.  
While adaptations to the environment can be seen as beneficial for the individual, they carry health 
consequences that are often far-reaching. The timing of puberty, circulating hormone levels and 
reproductive life span all affect cancer predisposition, while age at menopause is not only 
consequential for women who postpone pregnancy until later life, but is also associated with the 
onset of osteoporosis and age-related mortality1. Furthermore, in the clinic, diagnostic standards are 
typically derived from data of women in industrial, northern and/or western countries, where levels 
of circulating hormone are characteristically higher than in women living in other settings35. 
Increasing numbers of women are migrating around the globe and seeking medical care from doctors 
who are often only familiar with normative standards from these restricted populations. It is 
therefore imperative to characterise these adaptive responses and elucidate the mechanisms 
responsible, so that the clinicians can make more informed decisions. Clarification of some of these 
mechanisms might also open the way for developing novel clinical approaches to adjust the 
reproductive phenotype by targeting the epigenome.  
In this review, we address the enigma of how adult reproductive function can be shaped by 
childhood events. We also examine the evidence for the epigenetic regulation of key regulatory 
genes that govern the central control of reproduction and thereby emerge as pivotal elements in the 
adaptive response. We discuss this conceptual approach in understanding how variation in 
mammalian reproduction is regulated epigenetically, and emphasize the need for multifaceted 
approaches to elucidate this intriguing aspect of human biology.  
 
[H1] Plasticity of human reproduction  
[H2] Reproductive phenotypes adapt to the environment 
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The human reproductive phenotype seems to be well programmed, with sexual maturation and 
menopause typically occurring within predictable age ranges in a given population36,37. The 
constraints on the timing of these events remain largely a mystery, but the central control of 
reproduction involves a complex interplay between numerous physiological systems which, when 
challenged, reveals considerable plasticity and adaptation to environmental conditions. 
Changes in reproductive function comprise both rapid responses to immediate challenges (such as 
physiological, metabolic or psychological stress) and long-term adaptation to the environment in 
order to optimize individual survival and reproduction under diverse conditions1,38. This plasticity 
ensures that, during times of abundance, investment can be made in multiple physiological systems 
including growth, maintenance, and reproduction. However, in the face of harsh conditions and 
deprivation (e.g. infection or nutritional deficit), fewer resources can be allocated to reproduction, 
which might even be shut down39,40. Life history theory describes and rationalizes such trade-offs in 
varying environmental conditions where the costs of immediate and even future reproductive 
activity are assessed against the need to invest in individual maintenance and survival41–43. (Fig 1). 
In accordance with the prevailing environmental conditions, age at normal pubertal onset varies 
across populations and between 1890-1990 advanced by as much as 3 y in industrialized countries44. 
Many of these changes are associated with nutritional status, improved health and increased growth 
rates, although some studies have highlighted differences between distinct ethnic groups45–54. 
However, the role of environment, as distinct from genetics, was shown in a series of studies in male 
and female Bangladeshis, some of whom migrated to the UK. In these studies, age at puberty was 
later in children who had grown up in Bangladesh compared to those who had migrated to the UK as 
young children or were second generation migrants; the latter two groups entered puberty at a 
similar age to their European-ethnic neighbours7,55,56. Other studies have also reported shifts in age of 
pubertal onset in migrant populations, some of which have been attributed to ‘catch-up growth’, 
although the advancement of puberty following migration is apparent also in children who do not 
come from deprived backgrounds6,46,57. 
Adult reproductive function also varies between individuals who grow up in different environments 
(Table 1). Lower average reproductive hormone levels are consistently reported in populations who 
live in more energetically-challenging environments58–65. In people with Bangladeshi heritage who 
were born in the UK or migrated there as young children, progesterone levels in women and 
testosterone levels in men are markedly higher than those of individuals who grew up in Bangladesh, 
and similar to those of UK-born ethnic Europeans6,7. Despite progesterone levels that would be 
considered insufficient in Western clinics, individuals in non-industrialized societies are fertile, 
suggesting distinct programming to allow reproductive function within these lower hormonal 
ranges35,61,66.  
Compared with women who grow up in developed countries, women who grow up in less developed 
countries characteristically experience menopause at a younger age, in addition to having a later 
puberty, and this is also dependent on childhood environment5,56,67,68. The longer reproductive life 
span and elevated hormone levels seen in Bangladeshi child migrants to the UK were not observed in 
women who migrated as adults, even after spending a considerable number of years in the UK, 
indicating that the childhood environment is the main determinant of this adult phenotype5,6.  
[H2] Responses to early-life adversity vary  
Although changes to the early-life environment can induce adaptive responses in pubertal timing and 
adult reproductive function, the actual consequences of exposure to adverse events can be puzzlingly 
diverse4,8,13. It should be noted, however, that most scientific studies are carried out in western, 
educated, industrialized, rich and democratic populations, in which lifestyles and nutrition are far 
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removed from those of our ancestral environments as hunter-gatherers, and in extant foraging 
societies4,69. In fact, differing responses are seen in populations with distinct cultures. For example, in 
developed countries, girls who experience paternal absence during childhood are widely reported to 
have an earlier puberty relative to their peers, while in less developed countries, girls exposed to 
similar events show either no change or even delay in pubertal onset4,70,71. These findings suggest 
that the distinct outcomes are due to differences in the physiological or metabolic states in these 
girls, which are determined by their environment.  
Physiological responses to adversity imposed by harsh conditions, are usually energetically costly, as 
exemplified during inflammation or infection by the proliferation of immune cells. In states of limited 
resources, trade-offs are required between these physiological systems as described in life history 
theory12,72,73. In fact, chronic inflammation during childhood is often associated with pubertal 
delay74,75, while an increased level of body fat in Amazonian forager children was seen to endow 
them with protection from growth-inhibiting effects of acute inflammation73. Thus, the specific 
outcome of early-life adversity on reproductive function almost certainly varies according to the 
availability and allocation of resources. (Fig 1). 
The hypothalamic–pituitary–adrenal (HPA) axis has a key role in allocation of metabolic resources 
through the centralized ‘stress response’, which affects reproduction as well as growth and 
homeostasis. Increased stress and elevated cortisol are usually associated with reduced reproductive 
function and delayed puberty76–78; however, the stress response also seems to mediate the effects of 
poor nutrition on the timing of pubertal onset, as seen in stressed rats fed a Western diet (high levels 
of refined sugars and saturated fats, and low fiber content) in which normal pubertal timing was 
restored following environmental enrichment11. Moreover, the set-point of the HPA axis can be 
changed following early-life trauma, resulting in chronically altered circulating cortisol levels, while 
stress responses are attenuated in some metabolic states, such as conditions of low visceral adipose 
tissue79–82. It is clear, therefore, that understanding the mechanisms behind adaptive reproductive 
strategies needs to take into account the complexities of the wide-ranging physiological context.  
[H2] Population studies, big data and finding the role of epigenetic programming  
One of the ways to overcome the difficulties faced in analyzing data with large variation is by looking 
at extensive cohort studies of human populations. This approach has revealed altered reproductive 
phenotypes that correlate with stressful conditions amongst diverse populations83–88. Many of these 
databanks maintain records of circulating hormone levels, which can inform about reproductive 
competence and state of the ovarian reserve, and some also have blood or buccal DNA methylation 
data that might relate to the phenotypic variation. Such connections, however, are problematic given 
that methylation patterns differ across tissues89,90, providing an ambiguous link between any changes 
observed in these proxy tissues, which do not express most of the key factors that regulate 
reproductive function, and epigenetic modifications present in the functional tissues89,90. Therefore, 
understanding the underlying mechanisms behind these observations remains challenging, both due 
to inaccessibility of relevant tissues, and also because cause and effect are very difficult to discern 
from longitudinal datasets. 
Epigenetic modifications have been proposed to underlie altered adult phenotypes in response to 
early-life events, as described in the context of Developmental Origins of Health and Disease 
(DOHaD)91,92.  However, evidence to date for such modifications in the context of the central control 
of reproduction remains mostly indirect, in contrast with the metabolic and stress axes for which 
human and animal studies have demonstrated more fully a role for epigenetic modifications in 
adaptive responses to external signals93–95. Glucocorticoids play a central role in the modified stress 
response as demonstrated by the epigenetic re-programming of genes in the HPA axis, including the 
glucocorticoid receptor95,96. Furthermore, glucocorticoid catabolism is decreased through reduction 
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in the steroidogenic enzyme 5α reductase-1 in the liver, which was proposed to increase levels of 
active cortisol in order to enhance fuel output80.  
We have found that a cis-regulatory region of SRD5A1, the gene that encodes 5α reductase-1, is 
more methylated in buccal DNA of Bangladeshi women who had grown up in Bangladesh rather than 
in the UK. This gene was also more methylated and its expression down-regulated in a mouse model 
of early-life adversity that we used to study the epigenetic basis for the women’s adaptive 
reproductive phenotype (B.B.-S., L.P., Kurshida Begum [K.B.], Gregory Leeman [G.L.], Richard D. Emes 
[R.D.E.], R.S., G.R.B., P.M. unpublished work). In the hypothalamus, this enzyme moderates activity of 
the HPA axis as well the hypothalamic-pituitary-gonadal (HPG) axis through the production of 
neurosteroids97–99 , so appears to function as an epigenetically-regulated sensor that can determine 
the appropriate resource allocation to each of these axes in challenging environments. 
 
[H1] Windows of susceptibility 
[H2] DOHaD and adaptive programming during fetal development 
The concept of DOHaD is firmly rooted in the gestational period, having arisen from David Barker’s 
observations of differences in birth weight across England, and the associated later health 
outcomes100. Accordingly, most studies on the effects of early-life events on later health and disease 
have focused on very early stages of development, during which the patterns of gene expression that 
direct differentiation and organogenesis first become established. Barker and others have described 
fetal metabolic programming, as determined by the nutritional state during gestation, as shaping the 
trajectory of resource allocation and thus also health throughout later life93,101–103. At least some of 
these effects were seen to occur independently of the uterine environment, strongly supporting an 
epigenetic component102–104. 
Maternal nutrition has been shown repeatedly to affect DNA methylation patterns in the offspring of 
various mammals105. Notably, the level of methyl donors in the maternal diet at conception was seen 
to alter methylation levels at several metastable epialleles in the children of women from rural 
Gambia106. In mice, maternal nutrition was noted to influence methylation in the off-spring at several 
imprinted genes, as well as leptin and Ppara and a number of genes encoding chromatin 
modifiers9,107–110. Changes in the epigenetic landscape, most notable at genes like these that encode 
factors regulating growth and metabolism, have been proposed to affect the offspring’s metabolic 
phenotype as part of an adaptive response to the early-life adversity111. This adaptive response 
results in altered birth weight and childhood growth rates, nutritional state and metabolic rates all of 
which have key roles in pubertal timing, as seen in the early pubertal onset of low birth weight 
children that undergo “catch-up” growth112–114.  
Poor maternal nutrition and low birth weight of female offspring are also associated with a decrease 
in the size of ovarian reserve, which is evident in earlier reproductive senescence in women and rats 
115–120. The pool of germ cells is established during gestation, and in the female reaches a finite 
number, such that events during this time can have a marked effect on female reproductive function 
later in life. The effect of the uterine environment on the offspring’s ovarian development is seen in 
neonatal rats born to nutritionally-deprived mothers, which contain more activated primordial 
follicles and altered levels of PI3K–Akt signaling (which regulates follicle recruitment)121. 
Further to these data, after pubertal onset, reduced rates of ovulation and disrupted estrous cyclicity 
are reported in many women who had low birth weights and those born to nutritionally-deprived 
mothers, and this is also observed in mice121–123. The fact that infants born small for gestational age 
have elevated circulating FSH levels indicates that the central control of reproduction is also modified 
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in these individuals124. Indeed, the neuroendocrine regulation of reproduction is being established 
and primed during fetal development, including the sexual dimorphic masculinization of the male 
brain by fetal-origin androgens, further contributing to the sensitivity of the fetal period to epigenetic 
perturbations125. 
[H2] The neonatal period and ‘mini-puberty’ 
The hypothalamus and pituitary undergo considerable postnatal maturation to establish the central 
mechanisms that regulate reproduction in the adult126–128. Changes in epigenetic modifications during 
the key developmental stages thus continue to have a role in adaptive reprogramming in response to 
the neonatal and childhood environment, possibly via distinct mechanisms depending on the age of 
exposure and fluctuations in growth and metabolism that characterize these stages. (Fig 2).  
During the ‘mini-puberty’, which occurs in the first few months of life, activity of the hypothalamic–
pituitary axis is stimulated due to the immediate postnatal drop in steroid negative feedback127,129. In 
boys and male rodents, this activity includes a very rapid and transient testosterone surge on the day 
of birth125,130–132. The hormonal changes during this time modify hypothalamic neuron growth and 
development, gene expression patterns and the epigenome, and the androgen exposure leads to 
unique characteristics associated with brain masculinization (starting during the latter part of fetal 
development). Therefore, this neonatal period comprises a clearly defined window which is, at least 
in part, sexually-dimorphic125,132.  
The process of hypothalamic maturation during this time is acutely sensitive to nutritional state, 
particularly the kisspeptin neurons in the arcuate nucleus that regulate gonadotropin releasing 
hormone (GnRH) synthesis and secretion. The development of these cells is adversely affected by 
poor nutrition, which is reflected in reduced neuron density, reduced Kiss1 and GnRH expression and 
changes in age of pubertal onset and fertility133–135. Moreover, the testosterone surge in these first 
few postnatal months was reported to correlate with growth and metabolism in early 
childhood136,137, which likely affects pubertal timing. 
The gonadotrope population of the pituitary also undergoes dynamic change in the neonatal period, 
with a transient wave of expansion of precursor cells that undergo proliferation and differentiation. 
In mice, this includes epigenetic re-programming, some of which involves a major drop in the 
expression of ten–eleven translocation methylcytosine dioxygenase1 (TET1) DNA 
hydroxymethylase23. Subsequently, however, the numbers of gonadotropes are reduced to adult 
levels138,139 and the function of this temporary increase in hypothalamic–pituitary activity on later 
reproductive function is not clear. It is reasonable to assume, however, that this developmental 
phase also has a role in programming the central control of reproduction in the adult.  
[H1] Sensitive windows during childhood  
Early childhood is dominated by changes in growth and metabolism rather than reproductive activity, 
which is largely quiescent until the approach of puberty. However, numerous studies have pointed to 
early or mid-childhood as being a critical time for mediating the effects of adversity on reproductive 
function5–7,140–142. One reason for sensitivity at this time is the changing levels of hormones involved 
in somatic growth and bone maturation, which have a role in determining the timing of pubertal 
onset143. As noted, factors that regulate metabolic function seem particularly sensitive to epigenetic 
modification and changes in childhood growth rates or metabolic status certainly influence the timing 
of pubertal onset 126,144. Levels of body fat also vary considerably during this time, especially in 
girls145, which affects the trade-offs between homeostasis, growth and reproduction that occur in 
adverse conditions (Fig 1). Differences in the size and quality of these metabolic reserves might also 
explain some of the diverse responses in distinct populations.  
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At around 5-8 years of age, children undergo adrenarche, signalling maturation of the HPA axis and a 
dramatic increase in circulating levels of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS). 
These ‘weak’ androgens (i.e. they bind the androgen receptor with low affinity) can be converted to 
stronger androgens or estradiol in specific tissues, including the brain, gonads, liver and adipose 
tissue146, which allows them to bind the steroid receptors and presumably trigger epigenetic 
modifications. DHEA and DHEAS exert a multitude of actions, including modifying neurotransmitter 
receptors in the central nervous system, modifying the stress and immune responses and affecting 
bone density and metabolism146, any of which might affect pubertal timing and/or the central 
regulation of reproduction. In adults, they also act on the ovary directly, increasing circulating Anti-
Müllerian hormone (AMH) levels as well as the ovarian response to stimulation, suggesting their role 
in ovarian follicle recruitment147,148. The broad effects of these androgens, including their direct 
effects on the HPG axis, corroborate the likelihood that early-to-mid childhood comprises a major 
developmental milestone in reproductive programming. This observation is supported by studies in 
the Bangladeshi migrants, in which 8 years of age was found to be a critical ‘cut-off’ age in girls and 
boys that influenced the adult reproductive phenotype5–7. 
Most studies suggest that early-life is the principle phase during which adaptive reprogramming 
occurs. Changes in the epigenome, however, continue throughout the lifespan, both during normal 
developmental processes and in response to specific environmental signals, and are pivotal in the 
onset of puberty. The epigenome then continues to mediate the central control of reproductive 
function, sustaining the reproductive trajectory established by the early-life programming, while also 
endowing some responsiveness to changes in the immediate environment of the adult.  
 
[H1] Epigenetics in central control of reproduction  
[H2] Genetics reveals epigenetically-regulated genes involved in pubertal timing  
The timing of pubertal onset is clearly affected by the environment, but genetics also comprises a 
major determinant, with common and rare genetic variants having a role in the normal disparity seen 
in homogenous populations149. Unsurprisingly, many of these genetic variants are in key components 
of the HPG axis, such as genes encoding kisspeptin, GnRH, luteinizing hormone (LH) and follicle 
stimulating hormone (FSH) and their receptors150. Identification of genetic mutations associated with 
pubertal timing in the clinic has led to the discovery of novel epigenetically-regulated decisive 
factors, such as Makorin ring finger 3 (MKRN3) which represses the onset of puberty151–154. MKRN3 is 
an E3 ubiquitin ligase, and although its function in sexual maturation is not yet known, it is expressed 
highly in the arcuate nucleus (ARC) before puberty, drops markedly with pubertal onset and remains 
thereafter at low levels. Moreover this gene is imprinted and normally expressed only from the 
paternal allele due to methylation-mediated repression of the maternal allele155. Similar studies 
revealed mutations in Delta-like 1 homolog (DLK1) to be strongly associated with precocious puberty 
as well. DLK1 is also a paternal-allele expressed imprinted gene whose expression levels in the 
hypothalamus fall at puberty156. The fact that both genes are programmed primarily via DNA 
methylation, and expressed from just one allele, renders them particularly susceptible to 
perturbation of epigenetic states with consequence on pubertal timing. Moreover DLK1, which is also 
known as preadipocyte factor 1, represses adipogenesis and is highly likely to be regulated by 
changes in the metabolic state, providing a novel mechanistic link between metabolism and 
reproduction157.  
GWAS have identified several factors associated with age at menarche, which might comprise novel 
epigenetically-regulated targets to mediate adaptive responses, especially given that many of them 
regulate body weight or metabolism158–162. One example CRTC1 (which encodes CRTC1 or Transducer 
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Of Regulated CAMP Response Element-Binding Protein 1 (TORC1)) has been linked to age at 
menarche162 and mediates the effects not only of nutritional status on metabolic programs, but also 
controls reproduction directly through activating Kiss-1 and the genes that encode both subunits of 
FSH163–166. It is not yet clear to what degree CRTC1 activity is determined by epigenetic regulation, 
although it is apparently regulated by the deacetylase Sirtuin1167. 
 
[H2] Reproductive neuroendocrinology, epigenetics and connections with metabolism  
The links between metabolic state, pubertal onset and reproductive function are well 
recognized27,28,144,161,168. Furthermore, changes in metabolite levels can directly alter the epigenome 
due to their role as cofactors for several key chromatin-modifying enzymes169–171; however, not much 
is known about how these two fields meet in the context of the neuroendocrine control of 
reproduction. 
Pubertal onset hinges on a number of central neuroendocrine pathways that lead to reduced 
inhibition and increased activation of GnRH secretion, with pivotal stimulation by Kisspeptin161,172–174. 
Increased Kiss1 promoter activity is mediated by a reduction in polycomb repressive complex (PRC) 
proteins CBX7 and EED, as well as GATAD1, which recruits KDM1A that removes activating H3 lysine 4 
(H3K4) methylation16,175.   Subsequently, two activating lysine methyl transferase complexes, KMT2A 
(MLL1), which catalyzes trimethylation of H3K4 at the Kiss1 promoter, and KMT2C (MLL3) which 
binds a distal Kiss1 enhancer, activate expression of the gene 17. (Fig 3). 
It is not yet known whether these neuroendocrine processes respond to external signals to mediate 
changes in the timing of puberty, other than for a mechanism that was suggested to involve Sirtuin 
enzymes, whose deacetylase activity is regulated by the metabolic state18. Prior to pubertal onset, 
the nutrient-sensitive histone deacetylase, Sirtuin1, represses Kiss1 expression through interaction 
with the PRC complex18. Sirtuins require NAD+ as an essential cofactor, and in cases of nutritional 
excess, NAD+ is utilized heavily which might restrict Sirtuin activity and reduce this repression169–171. 
Therefore, in conditions of pre-pubertal over nutrition, the weakening of PRC-mediated inhibition 
that occurs towards puberty could be further facilitated by a drop in Sirtuin 1 activity, leading to 
precocious puberty. Conversely, under nutrition might have the opposite effect, delaying puberty 
due to enhanced Sirtuin 1-mediated repression of Kiss118. 
Due to their utilization of α-ketoglutarate (αKG) as a cofactor, the DNA hydroxymethylase and/or 
demethylase TET enzymes are also sensitive to the metabolic state, and changes in αKG availability 
have been seen to regulate levels of DNA methylation and hydroxymethylation176,177. Increased GnRH 
expression during neuronal maturation in rhesus monkeys correlates with decreased DNA 
methylation at its promoter, suggesting relief of epigenetic mediated repression19. Furthermore, 
TET2 levels in the preoptic area increase through development in mice and this appears to facilitate 
GnRH expression. Although TET2 knockout did not affect pubertal onset, it resulted in reduced levels 
of circulating LH and reduced fecundity in males, suggesting a role in maintenance of GnRH neuronal 
function20. It is feasible that nutritional state might therefore also affect GnRH levels through 
moderating TET2 activity on the Gnrh promoter. 
The pituitary gonadotropes respond to the metabolic state through direct sensing of altered 
glycaemic environment and resulting changes in glycolysis24. Ambient hyperglycaemic conditions lead 
to a major metabolic imbalance in these cells, including elevated levels of αKG and a drop in 
NAD+:NADH ratio, which affect TET and Sirtuin enzyme activity. Consequently, the gonadotrope 
epigenome undergoes a decrease in 5mC and increase in 5hmC DNA methylation, and elevated levels 
of histone acetylation24. The primary effect of these changes is a reduction in Fshb expression and 
circulating levels of FSH, which would be expected to affect female fertility24. In accordance with 
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these findings in mice, young girls with type 2 diabetes mellitus have steroid profiles that reflect low 
FSH levels, and worryingly, their menstrual dysfunction is reported not to improve following 
extensive anti-hyperglycemic treatment178. This outcome is highly suggestive of an epigenetic basis to 
their poor reproductive function, with implications for administering the most appropriate 
treatments.  
[H2] Importance of the chromatin landscape  
The functionality of an epigenetic modification can only be understood if studied in the relevant 
chromatin context. The mode of regulating a particular gene’s expression is determined by the 
chromatin organization at its proximal promoter and often numerous distal transcriptional 
enhancers, which define how the gene can be activated or repressed. This chromatin landscape 
comprises the DNA and the packaging histone proteins, and how these are organized and modified 
(Box 1). The DNA sequence determines potential regulation by DNA methylation and 
hydroxymethylation, and also influences nucleosome positioning and the way in which the DNA is 
packaged into nucleosomes179. The nucleosome packaging varies also due to the inclusion of histone 
variants and covalent histone modifications, both of which can alter the DNA-histone interactions as 
well as the stability and mobility of the nucleosomes25,180–182. This organization is instrumental in 
determining the mechanisms that are involved in regulating gene transcription and expression levels 
and how they might be perturbed, and its study is thus essential to appreciate the possible function 
of any differential epigenetic modifications detected in large population screens25,180,183,184.  
The gonadotropin LH α and β subunit-encoding genes provide an example of how very different 
chromatin packaging explains not only their distinct expression levels and unique methods of 
regulation, but also their respective propensities to epigenetic regulation15,25,185. Transcription of Cga, 
which encodes the common gonadotropin α subunit, is initiated quite easily due to the activity of a 
cell-specific distal enhancer that directs open chromatin at the proximal promoter, leaving it free 
from nucleosomes in gonadotrope cells25,26. This chromatin organization allows unobstructed access 
of the regulatory transcription factors and general transcription machinery to the transcriptional start 
site (TSS) of the gene. The major barrier for up-regulating transcription is therefore traversing the 
first (+1) nucleosome, which is downstream of the TSS, and transcription is stimulated through 
targeting this nucleosome25. The +1 nucleosome is made less stable by incorporation of the histone 
variant H2A.Z, and this reduced stability helps RNAPII passage through the nucleosome, which 
increases rates of transcription25. The transcriptional up-regulation of this gene by GnRH also involves 
induction of several activating histone modifications, including H3 phosphorylation and acetylation, 
which reduce the histone tail-DNA interaction, likely also contributing to the transcription 
efficiency14,25,183. (Fig 3). 
The potential regulation by DNA methylation of these genes is also distinct. In contrast to Cga, which 
virtually lacks CpG sites on its proximal promoter, Lhb is tightly regulated by DNA methylation and 
the TET enzymes23. In gonadotrope precursor cells, expression of Lhb is repressed by TET1 through 
non- catalytic mechanisms. However, TET1 expression is down regulated during development, and in 
fully-differentiated gonadotrope cells, its place on the Lhb gene promoter is replaced by TET2 which 
catalyzes the activating hydroxymethylation at this locus23. (Fig 3). 
Also in marked contrast to Cga, the Lhb promoter is packaged in a nucleosome, which covers the 
binding sites for the crucial Lhb activating transcription factors, Sf-1, Pitx1 and Egr-115,25. Expression 
of Lhb thus requires remodelling of the promoter chromatin to allow transcription initiation. This 
remodelling involves incorporation of H2A.Z into the promoter nucleosome, which increases its 
mobility on the DNA and facilitates transcription factor binding15. This nucleosome is also covalently 
modified following gonadotrope exposure to GnRH, which increases recruitment of menin, a key 
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component of the KMT2A and/or KMT2B methyl transferase complex that is responsible for the 
activating H3K4me3 modification at the gene promoter21. (Fig 3).  
The chromatin landscape of Fshb has yet to be determined in such detail, but earlier studies reported 
that this gene is repressed in partially differentiated gonadotrope cell lines by class I and class II 
histone deacetylases (HDACs) whose actions are overcome by GnRH22,186–188. This repressive role for 
HDACs has been confirmed more recently also in primary gonadotrope cells from sexually immature 
mice, in which GnRH was seen to increase levels of histone acetylation at the Fshb gene promoter 
(L.P and P.M unpublished work). The repressive actions of HDACs on this gene and the ability of 
GnRH to overcome their actions likely comprise a key repressive mechanism that is lifted at the time 
of puberty when GnRH levels increase. (Fig 3). Further studies are required to understand the role of 
these and other epigenetic-driven mechanisms that mediate adaptive changes in reproductive 
function in response to the environment. 
 
[H1] Identifying the epigenetic drivers  
[H2] Reproduction, epigenetics and ageing: cause and effect  
One of the shortcomings of trying to understand phenotypic variation by looking at human cohort 
methylome data, is being able to decipher cause from effect189. Methylome analyses have been 
performed in girls and boys across puberty using peripheral leukocytes or blood mononuclear cells, 
and in one study a causal relationship between the changes in DNA methylation and secondary 
sexual characteristics was inferred190. However, gonadal steroids are known to modify the 
epigenome29–31, and two such studies reported particular enrichment for differential methylation at 
regions close to estrogen receptor binding sites or E2-responsive genes, which suggests that the 
altered methylation might be mediated by the increase in steroids191,192. As noted by these authors, it 
is not possible to determine from these observations whether the epigenetic changes are the result 
or the cause of the hormonal changes. Bessa and colleagues192 also examined changes in CpG 
methylation in individuals with central precocious puberty (CPP), and identified 48 hypermethylated 
ZNF protein-encoding genes; which they acknowledged might contribute to CPP, but equally might 
result from functional changes in the genetic network underlying this condition.  
Global levels of DNA methylation normally change over the lifespan, known as epigenetic drift or 
ageing193,194, and this too is affected by activity of the reproductive axis. Some CpG sites show more 
variation over time than others, and when taken together they reflect quite precisely the ageing 
process. This observation has led to the development of predictive tools of chronological age, termed 
‘epigenetic clocks’195,196. The tick-rates of such epigenetic clocks are affected by various factors 
including environmental influences, and they correlate remarkably well with general health195,197–200. 
Importantly, the pace of epigenetic ageing is altered following puberty and menopause, and in 
certain tissues specifically in response to estradiol32–34,201,202. Thus, early-life environmental exposures 
or events that alter reproductive trajectories, including age at puberty or circulating hormone levels, 
would likely affect epigenetic ageing. So here too, differences observed in the methylome might 
reflect the altered reproductive function but are not necessarily responsible for the individual’s 
phenotype. Deciphering how these changes in DNA methylation profiles relate to environmentally-
modified reproductive strategies and the molecular mechanisms involved, requires additional 
experimental approaches, first to address whether the modification is in fact altered in the functional 





[H2] Animal models, tissue accessibility and functional adaptive strategies 
DNA methylation patterns vary between tissues, and in easily-attainable proxy tissues are not 
necessarily the same as in the relevant functional tissues89,203,204. Animal models can therefore be 
valuable for dissection of the relevant tissue, further facilitated by expression of fluorescent markers 
that allow isolation of specific cell populations. Enrichment of specific cell types is especially 
important for epigenetic profiling in heterogeneous tissues such as the pituitary23,205, where the 
gonadotrope cells make up only a small percentage (3–10%) of the gland139. Without such isolation of 
the particular cell type, erroneous assumptions about differential epigenetic modifications can be 
made following changes in the relative population sizes rather than epigenetic changes per se in the 
cells of interest.  
Animal models also present some of the complexities of the physiological and metabolic backgrounds 
that might mediate the adaptive response. Their energetic state can be manipulated, to some 
degree, to mimic specific human environments, although the parallels here are clearly limited, and 
new animal models that more accurately represent human biology are needed. Among rodents, the 
spiny mouse (Acomys cahirinus) is unique in experiencing human-like menstruation, and also post-
natal maturation of the adrenal zona reticularis, mimicking changes in circulating adrenal androgen 
levels that occur during adrenarche206,207. Such characteristics suggest that this species might be 
more suitable for study of reproductive and adrenal function than commonly used rodent models. 
Mouse lemurs (Microcebus spp.) have also been heralded recently as a particularly suitable new 
model for studying human physiology and disease208,209; they share advantages of mice due to their 
small size, and breeding rates and capacities but, as primates, are genetically closer to humans.  
Adopting new research models presents many technical drawbacks and hurdles, and ethical 
opposition, especially for primate research209. However, the information that appropriate animal 
models can contribute to identifying the mechanisms responsible for adaptive responses is 
invaluable, evident in our study on the Bangladeshi migrant populations in which we integrated 
findings from methylation analysis of human buccal DNA and a mouse model of early-life stress to 
mimic challenges of the Bangladeshi environment  In this way we were able to identify altered 
epigenetic signatures of several genes that regulate ovarian follicle recruitment and appear to explain 
the depleted ovarian reserve in the women who spent their childhoods in Bangladesh (B.B.-S., L.P., K. 
B., G.L., R.D.E., R.S., G.R.B., P.M. unpublished work).  
[H2] Determining a function for the epigenetic modification  
Given the constant dialogue between the epigenome and reproductive axis, it is important that we 
verify whether a particular modification that is differentially-associated with a phenotype has a 
functional consequence. Discerning the importance of differential modifications at a specific genomic 
locus is usually challenging, unless found at known gene regulatory enhancers or promoters, which is 
highly indicative of function. Understanding the role of a modification on the expression of a 
particular gene requires knowledge of the chromatin landscape governing its transcription. High-
precision mapping of the nucleosome positions, identification of the regulatory proteins that bind 
this genomic region and how this binding is altered by the modifications, as well as an understanding 
of the higher order chromatin structure and the role of long non-coding RNAs, all need to be 
considered (Box 1). An overview of these techniques is beyond the scope of this Review, but it should 
be emphasized that chromatin organization at gene regulatory regions can vary considerably 
between expressing and non-expressing cells, as at the Cga proximal promoter, which is devoid of a 
nucleosome only in gonadotropes25. This type of analysis must therefore be performed in an 
appropriate cell type that normally expresses the gene of study.  
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Once the chromatin landscape is known, its manipulation, for example using CRISPR-Cas9 based 
targeting approaches, can be used to establish functionality in cultured cells, and potentially also in 
animal models210–212. For greater precision, single-molecule approaches in vitro can reveal exactly 
how epigenetic modifications affect the interactions of packaging and regulatory proteins with a 
specific DNA sequence. After reconstituting nucleosomes on the regulatory DNA to recapitulate the 
native chromatin landscape, the DNA can be ‘un-zipped’ using an optical trap, to reveal both the 
force of interaction at pico-Newton scale, and the protein position on the DNA at nearly base -pair 
resolution180,213. (Fig 4). In this way, we have deciphered the function of H2A.Z at the gonadotropin 
genes25 and revealed how a transcription factor binds chromatin-packaged DNA at the proximal 
promoter of Lhb15,214. This approach has the further potential to assess how epigenetic modifications 
affect RNAPII progression along the DNA, the effects of DNA and histone modifications as well as 
additional histone variants on nucleosome stability and mobility, and how these processes regulate 
the recruitment and effects of regulatory DNA-binding transcription factors. Clarification of the 
impact of epigenetic modifications that participate in adaptive reproductive strategies, at this level of 
resolution, is essential to complete our understanding of reproductive plasticity, and could facilitate 
the development of targeted approaches for modifying reproductive function.  
 
[H1] Conclusions 
The field of biological regulation is at one of its most exciting times. Human reproductive phenotypes 
are shaped by the environment and adult reproductive function can be reprogrammed following 
events during key developmental stages of early-life, as discussed here. Moreover, there is an 
expanding list of ways in which the chromatin can be modified through newly-discovered epigenetic 
modifications and regulatory non-coding RNAs that alter chromatin structure, providing seemingly 
endless mechanisms through which physiological function might be modified in response to external 
cues. Challenges ahead include integrating the roles of these potential regulators into our 
understanding of how the reproductive endocrine system operates normally and in adaptive 
responses to changes in the environment. 
In a wider perspective, the environment in the developed world has changed dramatically since the 
industrial revolution, and is continuing to do so as technological advances alter fundamentally our life 
styles. Changes in quantity and quality of our nutrition, pathogen exposure, levels of physical activity 
and stress, surely affect our physiology directly, but might also provoke such adaptive responses in 
reproductive function, with important implications for human health. Beyond determining the start 
and end of the reproductive life-span and rates of fertility, consequences extend to the broad impact 
of hormonal exposure and epigenetic ageing on health and senescence more generally. 
Understanding these complex aspects of human health is thus crucial and will require extensive, 
multi-pronged approaches, as highlighted in this review. On the positive side, epigenetic 
modifications can potentially be targeted, so elucidating the mechanistic basis of these adaptive 
processes at a molecular level could open the way for developing tools to modify a variety of 
reproductive phenotypes.  
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Box 1: Determinants of the regulatory epigenetic landscape  
The nucleotide sequence of DNA affects its mechanical properties, thus influencing nucleosome 
positioning, mobility and stability. The CpG content at regulatory DNA determines its potential 
regulation by DNA methylation and hydroxymethylation. DNA methylation recruits repressive protein 
complexes, so is usually inhibitory when occurring at gene promoters and enhancers, but likely has 
different roles in gene bodies. Hydroxylation of methylated cytosines can lead to active or passive 
demethylation, so facilitates transcription179,215.  
Nucleosome packaging of the DNA inhibits accessibility to regulatory proteins. For transcription to 
occur, nucleosomes must usually be destabilized, e.g. through incorporation of histone variants and 
covalent modification. This also facilitates nucleosome movement or eviction by ATP-dependent 
chromatin remodelers182,216.  
Histone variants alter various characteristics of the nucleosome: H2A.Z and H3.3 are histone 
variants commonly found at transcriptional start-sites of actively transcribed genes. H2A.Z 
incorporation increases nucleosome mobility and decreases stability. The role of H3.3 in transcription 
is less clear, but it was proposed to enhance accessibility of the chromatin to transcription 
factors15,25,217,218.  
Multiple histone modifications have diverse roles: Covalent histone modifications can signal 
recruitment of regulatory proteins, while some modifications alter the histone charge, possibly 
affecting interaction with the DNA or other histones. Histone acetylation is found in broad regions of 
active promoters and enhancers, and regulated by a number of histone acetyltransferases and 
deacetylases. Other histone modifications, like methylation, are more localized, catalyzed by fewer 
enzymes, and impart distinct effects depending on the number of modifications and specific histone 
residue targeted219.  
Functional enhancer RNAs: Transcriptional enhancers are often transcribed into noncoding RNA 
(eRNA), whose functions are beginning to emerge, but could vary in different contexts. Some eRNAs 
have been shown to regulate the proximal promoter chromatin landscape profoundly and play a role 
in enhancer-promoter DNA looping26,183.  
Higher-order chromatin: Chromatin 3D organization creates domains which both limit and mediate 
regulatory interactions. These domains change through development, and determine long-range 




Box 2: Glossary of Terms  
5mC and 5hmC: 5-methylcytosine or 5-hydroxymethylcytosine modifications of the DNA.  
Adrenarche: post-natal maturation of the adrenal gland which occurs almost uniquely in humans at 
ages 5-8 years and results in activation of 17,20-lyase activity and decreased 3β-hydroxysteroid 
dehydrogenase activity in the zona reticularis, greatly increasing circulating levels of DHEA and 
DHEAS.  
Catch-up growth: a period of rapid growth that often occurs in children after their removal from 
growth-inhibiting conditions, and allow attainment of the expected final height.    
Chromatin: packaging of the DNA around the histone proteins, the nature of which determines DNA 
accessibility.  
CpG: a cytosine nucleotide followed by a guanine nucleotide, in the 5’ to 3’ direction. 
CPP: central precocious puberty, when secondary sexual features appear before 8 years of age due to 
early activation of the HPG axis and elevated circulating gonadotropin levels.  
DHEA and DHEAS: dehydroepiandrosterone and dehydroepiandrosterone sulfate: “weak” androgens 
(i.e. they bind the androgen receptor with low affinity) produced in humans largely by the adrenal 
glands following adrenarche. 
DOHaD: developmental origins of health and disease.  
FSH: follicle stimulating hormone, the pituitary hormone that stimulates follicle growth in females 
and conversion of weak androgens to strong androgens or estrogens in both sexes. It is composed of 
a common α-subunit (encoded by CGA) and a hormone-specific β-subunit (encoded by FSHB).  
GnRH: gonadotropin releasing hormone, the hypothalamic hormone that stimulates the pituitary to 
produce and release the gonadotropins, LH and FSH. 
Gonadotrope: the pituitary cell that synthesizes and secretes the gonadotropins, LH and FSH. 
Gonadotropins: the pituitary hormones, LH and FSH. 
HATs and HDACs: families of enzymes acting as histone acetyl transferases (HATs) or histone 
deacetylases (HDACs).  
HPA axis: hypothalamic-pituitary-adrenal endocrine axis that regulates adrenal function, homeostasis 
and the stress response. 
HPG axis: hypothalamic-pituitary-gonadal endocrine axis that regulates reproductive function. 
KMT and KDM: families of enzymes acting as lysine methyl transferases (KMTs) or lysine 
demethylases (KDMs).  
LH: luteinizing hormone, the pituitary hormone that stimulates ovulation and corpus luteum 
formation and progesterone synthesis in females, and androgen synthesis in both sexes. It is 
composed of a common α-subunit (encoded by CGA) and a hormone-specific β-subunit (encoded by 
LHB).  
Menarche: the first cycle of menstrual bleeding in girls 
NAD +/NADH: Nicotinamide adenine dinucleotide (NAD) and its reduced form (NADH); involved in 
electron transfer in cell metabolism, they also act as cofactors for many enzymes, including the 
Sirtuin histone deacetylases. 
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PRC: polycomb repressive complex which shuts down gene expression primarily through catalyzing 
repressive histone methylation.  
Puberty: the process of sexual maturation during which the HPG axis is activated, the gonads start to 
produce sex-specific steroids in large amounts and the potential for sexual reproduction is attained.  
RNAPII: RNA polymerase II that transcribes most protein-coding genes. 
TET enzymes: Ten-eleven translocation enzymes that catalyze the conversion of 5mC to 5hmC, as well 
as other less common modifications (5-formylcytosine and 5-carboxylcytosine) which can lead to 
demethylation. 
αKG: α-ketoglutarate (2-oxoglutarate) is produced during glucose metabolism following the 
deamination of glutamate, and is a crucial cofactor for several chromatin modifying enzymes, 
including the TET enzymes and most of the histone demethylases. 
 
Figure Legends: 
Figure 1: Life history theory of environmentally-induced reprogramming via the endocrine system. 
In response to changing environmental conditions and in the context of existing resources, resource 
allocation can be reprogrammed through the endocrine system to balance or shift between growth, 
homeostasis and reproduction, with the brain playing a central role, due to its ability to regulate all 
three endocrine axes.  
 
Figure 2: Key early-life developmental stages in childhood and windows of susceptibility for 
reproductive axis re-programming. Fluctuations in pulsatile GnRH (top: adapted from128) and steroid 
levels (bottom: adapted from221) in boys and girls from late fetal development through sexual 
maturation; DHEA levels (adapted from222) are shown from birth (dashed line). These stages of 
hormonal fluctuations (shaded) reflect periods of changing epigenetic and gene expression networks, 
likely rendering them particularly vulnerable to modification. GnRH: gonadotropin releasing 
hormone; HPG: hypothalamic-pituitary-gonadal; T: testosterone; E2: estradiol; DHEA: 
dehydroepiandrosterone.  
 
Figure 3: Sites of epigenetic regulation reported in the central control of reproduction. Expression 
of the hypothalamic KISS1 and GNRH genes is inhibited in their respective neurons by factors shown 
in red. Activation of these genes involves removal of these repressors, and implementation of the 
activating epigenetic marks shown in green (most of the enzymes specifically responsible have yet to 
be identified). Similarly in the pituitary gonadotropes, a number of inhibitory factors (in red) have 
been identified that repress expression of the CGA, LHB and FSHB genes, and after their removal, 
activating marks (in green) are associated with gene expression. Data are taken from mouse model 
(refs in the main text). 
 
Figure 4: Integrating experimental approaches to understand the role of the epigenome in adaptive 
reproductive strategies in humans. (1) Association of methylation data with reproductive phenotypic 
variation in human cohort studies can be combined with (2) animal models to verify modification in 
the functional tissue. (3) Cell models can then be used to characterize the chromatin at this genomic 
region and determine which genes are affected. (4) Subsequently, in vitro studies, preferably at the 
single-molecule level, can reveal the actual function of the epigenetic modification in terms of 
structural characteristics of the nucleosome, transcription factor binding and progression of the 
polymerase along the DNA. Understanding phenotypic variation in reproductive function and how 
this is determined by early-life experiences through changes in the epigenome will inform the 
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clinician and could lead to novel approaches for intervention of reproductive function and associated 
health benefits.  
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